P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
| Autor: | Liefers, G.-J., Kranenbarg, E. Meershoek-Klein, Carpentier, M. Duijm-de, van de Velde, C.J., Kleijn, M., Dreezen, C., Menicucci, A., Veer, L. van’t, Audeh, W. |
|---|---|
| Zdroj: | In The Breast April 2023 68 Supplement:S21-S21 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect